SSSamira Sahraeian

Samira Sahraeian

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Samira Sahraeian has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Hojjat Allah Abbaszadeh

    Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    3 shared publications
  • Mohammad Amin Edalatmanesh

    Department of Biology, College of Sciences, Shiraz Branch, Islamic Azad University, Shiraz, Iran

    3 shared publications
  • Robabeh Taheripanah

    Department of Obstetrics and Gynecology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    3 shared publications
  • Alaleh Ghazifard

    Infertility Clinic, Erfan Niayesh Hospital, Iran University of Medical Sciences, Tehran, Iran

    1 shared publication
  • Somayeh Keshavarzi

    Infertility Clinic, Erfan Niayesh Hospital, Iran University of Medical Sciences, Tehran, Iran

    1 shared publication

Latest Publications

  • Open Access

    Correction to: Extracellular Vesicle-Derived Cord Blood Plasma and Photobiomodulation Therapy Down-Regulated Caspase 3, LC3 and Beclin 1 Markers in the PCOS Oocyte: An In Vitro Study

    by Samira Sahraeian, Hojjat Allah Abbaszadeh, Robabeh Taheripanah, Mohammad Amin Edalatmanesh

    In the article titled "Extracellular Vesicle-Derived Cord Blood Plasma and Photobiomodulation Therapy Down-Regulated Caspase 3, LC3 and Beclin 1 Markers in the PCOS Oocyte: An In Vitro Study," published in J Lasers Med Sci 2023;14:e23 (doi: 10.34172/jlms.2023.23), there was an error in the Ethical approval section. The ethics approval code was incorrectly reported as: "The Ethics Committee at Shahid Beheshti Medical University in Tehran, Iran, approved the in vitro clinical study (IR.SBMU.MSP.REC.1401.416). Contributors agreed verbally and in writing to contribute to the study. Patients from Erfan Niyaish hospital (Tehran, Iran) donated oocytes for the current study between 2021 and 2022." The correct ethics approval code is: IR.SBMU.RETECH.REC.1401.223 The corrected sentence should read: "The Ethics Committee at Shahid Beheshti Medical University in Tehran, Iran, approved the in vitro clinical study (IR.SBMU.RETECH.REC.1401.223). Contributors agreed verbally and in writing to contribute to the study. Patients from Erfan Niyaish hospital (Tehran, Iran) donated oocytes for the current study between 2021 and 2022." This correction has now been updated in both the PDF and HTML versions of the article.

  • Open Access

    Exosome Therapy and Photobiomodulation Therapy Regulate mi-RNA 21, 155 Expressions, Nucleus Acetylation and Glutathione in a Polycystic Ovary Oocyte: An In Vitro Study

    by Samira Sahraeian, Hojjat Allah Abbaszadeh, Robabeh Taheripanah, Mohammad Amin Edalatmanesh, Somayeh Keshavarzi, Alaleh Ghazifard

    Introduction: Polycystic ovary syndrome (PCOS) is a complex condition that can have various symptoms and complications, one of which is infertility. Dysregulation of miRNA has been associated with the pathogenesis of numerous illnesses such as PCOS. In this study, we evaluated the effect of photobiomodulation therapy (PBMT) and exosome therapy (EXO) on the regulation of miRNA and nucleus acetylation in a PCOS oocyte. Methods: In this research, 36 oocytes divided into three groups: control, EXO, and PBM (Wavelength of 640 nm). Subsequently, in-vitro maturation (IVM) was evaluated. Real-time PCR was used to evaluate miRNA-21,16,19,24,30,106,155 and GAPDH. Afterward, oocyte glutathione (GSH) and nucleus acetylation were measured by H4K12. Results: The expression of the miR-16, miRNA-19, miRNA-24, miRNA-106 and miRNA-155 genes in the EXO and PBMT groups was significantly down-regulated in comparison to the control group, but the expression of miRNA-21 and miR-30 significantly increased in the EXO and PBMT groups in comparison to the control group. The EXO and PBMT significantly increased GSH and nucleus acetylation (P<0.0001). Conclusion: The results of this study showed that the use of EXO and PBMT can improve GSH and nucleus acetylation in the PCOS oocyte and also change the expression of miRNAs.


  • Open Access

    Extracellular Vesicle-Derived Cord Blood Plasma and Photobiomodulation Therapy Down-Regulated Caspase 3, LC3 and Beclin 1 Markers in the PCOS Oocyte: An In Vitro Study

    by Samira Sahraeian, Hojjat Allah Abbaszadeh, Robabeh Taheripanah, Mohammad Amin Edalatmanesh

    Introduction: Polycystic ovary syndrome (PCOS) is the communal endocrine illness in women and the most common cause of infertility due to lack of ovulation. The exact cause of PCOS is still unknown. Affected women may have difficulty getting pregnant due to ovulation problems. Various methods have not been effective in the treatment of PCOS due to the positive role of photobiomodulation therapy (PBMT) and extracellular vesicles (ECV) obtained from cord blood plasma in the treatment of various diseases. The aim of this study was to study the role of ECV and PBMT in maturation and improvement of infertility in women with PCOS. Methods: In this research, a number of oocytes were obtained after ovarian stimulation from women who had been referred to the hospital for infertility treatment after obtaining personal consent, and they were divided into three groups: control, ECV and PBMT. Subsequently, in vitro maturation (IVM) was assessed, then some oocytes were cultured with a routine medium and others were treated with ECV and PBMT. Real-time PCR was used to evaluate BCL-2, BAX, caspase-3, and autophagy gene (ATG5, LC3, Beclin 1). Oocyte glutathione (GSH), oxidised gluathione (GSSG), and reactive oxygen species (ROS) were measured. Results: The metaphase II (MII) oocyte ratio formation significantly increased in the ECV and PBMT groups (P<0.05). The expression of the BCL-2 gene was significantly up-regulated in the ECV and PBMT groups, but the expression of BAX and caspase-3 significantly decreased (P<0.05). The expression of the ATG5, LC3, BECLIN-2 genes significantly decreased in the ECV and PBMT groups (P<0.05). ROS, GSSG decreased in ECV and PBMT groups but GSH increased (P<0.05). Conclusion: The use of ECV and PBMT can increase the rate of fertilization and maturation of an oocyte and cause a decrease in apoptosis, autophagy, and ROS in a PCOS oocyte.